Establishing Immune Memory to Rabies in the CNS

| February 26, 2019

article image
Researchers from Philadelphia University and Thomas Jefferson University have highlighted how building a strong immune memory response to rabies virus in the brain and spinal cord is key to protecting the CNS against infection. The rabies virus belongs to the Lyssavirus genus and transmission of the virus to humans predominantly occurs through the bite of infected dogs. All mammals are believed to be susceptible to the virus, but children in poorer rural communities are disproportionately affected by the disease.

Spotlight

Pharmaceutical Solutions Industry Ltd "PSI"​

Dedicated to the development and manufacturing of pharmaceutical solutions with international quality standards, Pharmaceutical Solutions Industry Ltd. is a fully integrated pharmaceutical company thriving on a culture of innovation and excellence. 

 Pharmaceutical Solutions Industry is the leading, and the largest producer of a wide range of sterile IV solutions in the MENA region. 

Headquartered in Jeddah, Saudi Arabia, PSI has successfully grown to expand its portfolio catering to the needs of both domestic and international markets. 

As one of the Arab world's pioneering pharmaceutical companies, we are committed to providing the global healthcare market with life saving solutions. 

 PSI philosophy on the pharmaceutical production is that world competitive results can only be obtained with the best people, processes and technology. 

 With a workforce of 600 employees in addition to several full time consultants, PSI paves its way from planning to production for the quality, sa

OTHER ARTICLES

3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys?

Article | March 26, 2020

Big pharma stocks have been clobbered during the coronavirus-caused stock market crash. You can count the number of drugmakers with market caps of $25 billion or more whose shares haven't dropped by double-digit percentages on one hand -- and have several fingers left over. Three big pharma stocks have plunged the most: AbbVie (NYSE:ABBV), Bristol Myers Squibb (NYSE:BMY), and Pfizer (NYSE:PFE). But are these stocks smart picks to buy right now?

Read More

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Roche Prepares to Launch COVID-19 Antibody Test System

Article | April 17, 2020

Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2, the virus that causes COVID-19. Roche is eying May for the launch of the test in Europe and is in talks with the U.S Food and Drug Administration for emergency approval of the system. Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms, the company said. Roche noted that as more information becomes available about immunity levels to COVID-19, society can return to a sense of normal much more quickly. Roche’s test will join a number of other antibody tests that have recently come on the market. Earlier this month the U.S. Food and Drug Administration approved the first blood test for COVID-19 antibodies.

Read More

Top Specialty Pharmacy Therapy Areas

Article | March 16, 2020

Accelerated by advancements in cancer treatments and a growing emphasis on personalized and precision medicine, specialty pharmacy represents a rapidly growing sector within the healthcare industry. In fact, the market is projected to grow to $500 billion by the end of this year—up from $200 billion in total U.S. specialty drug spending in 2017. Industry growth of this magnitude creates challenges for those looking to understand and penetrate the market. It can be difficult, after all, to maintain updated information about high-priority drug therapy areas or facility affiliations in a market that’s constantly changing.

Read More

Spotlight

Pharmaceutical Solutions Industry Ltd "PSI"​

Dedicated to the development and manufacturing of pharmaceutical solutions with international quality standards, Pharmaceutical Solutions Industry Ltd. is a fully integrated pharmaceutical company thriving on a culture of innovation and excellence. 

 Pharmaceutical Solutions Industry is the leading, and the largest producer of a wide range of sterile IV solutions in the MENA region. 

Headquartered in Jeddah, Saudi Arabia, PSI has successfully grown to expand its portfolio catering to the needs of both domestic and international markets. 

As one of the Arab world's pioneering pharmaceutical companies, we are committed to providing the global healthcare market with life saving solutions. 

 PSI philosophy on the pharmaceutical production is that world competitive results can only be obtained with the best people, processes and technology. 

 With a workforce of 600 employees in addition to several full time consultants, PSI paves its way from planning to production for the quality, sa

Events